From Product to Platform: Henlius’ Practices & Progress in ADC to Address Unmet Medical Needs
Time: 9:00 am
day: Day One
Details:
- Review how ADC is a strategic R&D field of Henlius based on its 13+ year antibody capabilities and integrated R&D platform
- Explore the highlights of ADC assets' progress in clinical and pre-clinical stages
- Learn how Henlius is dedicated in building ADC platform – “Hanjugator”
